GLP-1 Medicines: Expanding Clinical Impact and Complex Mechanisms

Join the Lloyd “Holly” Smith Distinguished Lecture for a scientific presentation by Daniel J. Drucker, a world-leading endocrinologist and pioneer in peptide hormone biology. 

Drucker is renowned for his breakthrough discoveries of the biological actions of glucagon-like peptide hormone GLP-1. His research helped lay the biological foundations for the pharmacological revolution of GLP-1 based medicines that have transformed the treatment of type 2 diabetes and obesity. His discovery of the role of GLP-2 in intestinal barrier function has also led to a first-in-class, life-changing treatment for patients with short-bowel syndrome.

Mark your calendar for this special event to honor the late Holly Smith for his visionary leadership and to hear from Drucker about the science behind some of the most impactful advances in metabolic medicine.